Surgery Partners Inc header image

Surgery Partners Inc

SGRY

Equity

ISIN null / Valor 29308003

NASDAQ (2025-11-17)
USD 15.06-1.44%

Surgery Partners Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Surgery Partners Inc is a prominent healthcare services company with an integrated delivery model, owning and operating over 180 locations in 31 states. The company specializes in surgical facilities and ancillary services, including multi-specialty physician practices and anesthesia services. With a strong presence nationwide, Surgery Partners Inc is a leading operator in the healthcare industry, providing essential services to patients across the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (08.10.2025):

Surgery Partners Inc. reported its second quarter of 2025, showcasing an 8.4% increase in revenues. Despite achieving growth in several key areas, the company recorded a net loss attributable to itself of $2.5 million. Adjusted EBITDA saw a notable rise, and the company reaffirmed its full-year 2025 financial guidance.

Revenue Growth

For the second quarter of 2025, Surgery Partners Inc. achieved an 8.4% increase in revenues, rising to $826.2 million compared to $762.1 million in the same period last year.

Same-Facility Performance

Same-facility revenues saw a 5.1% increase, and the number of same-facility cases grew by 3.4% during the second quarter of 2025, indicating strong operational performance within existing facilities.

Adjusted EBITDA Improvement

Adjusted EBITDA for the second quarter of 2025 increased by 9.0%, reaching $129.0 million, reflecting enhanced profitability and operational efficiency.

Net Loss and Financial Position

Despite revenue growth, Surgery Partners Inc. reported a net loss attributable to the company of $2.5 million for the second quarter of 2025. The company's total net debt to EBITDA ratio stood at approximately 4.1x at the end of the quarter.

Full-Year Guidance Reaffirmed

The company reaffirmed its full-year 2025 guidance, projecting revenues between $3.30 billion and $3.45 billion and Adjusted EBITDA in the range of $555 million to $565 million.

Summarized from source with an LLMView Source

Key figures

-34.4%1Y
-44.3%3Y
-39.0%5Y

Performance

46.5%1Y
50.7%3Y
55.3%5Y

Volatility

Market cap

1931 M

Market cap (USD)

Daily traded volume (Shares)

2,350,121

Daily traded volume (Shares)

1 day high/low

20.87 / 20.37

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, Inc. Class B Bio-Rad Laboratories, Inc. Class B Valor: 912794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 310.70
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.81%USD 88.40
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.71%USD 84.87
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.75%USD 0.54
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.14%USD 17.55
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.71%EUR 15.54
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 257.01
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 13.56
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.42%USD 3.87
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 25.08